Preferred Medication for Acute Bipolar Mania: Comparing Two Landmark Studies
Bipolar disorder is a complex psychiatric condition requiring effective management strategies, especially during acute manic episodes. Managing acute manic episodes requires a careful selection of medications to help stabilize mood and prevent manic symptoms from escalating. Over the years, researchers have conducted numerous studies to identify the most efficacious and tolerable anti-manic agents. So, which medications are preferred for acute bipolar mania management?
So which medications are preferred for acute bipolar mania management?
In our academy’s bipolar disorder section, Dr. Harvinder Singh has compared findings from the following two pivotal studies to answer this question:
Cipriani et al. (2011): “Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis.” (pubmed)
Kishi et al. (2022): “Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.” (pubmed)
Key Findings: Cipriani et al. (2011)
This landmark meta-analysis compared 12 anti-manic agents across 68 randomized controlled trials (RCTs). Key results included:
(1) Most Effective Drugs:
- Olanzapine, Risperidone, Quetiapine and Haloperidol emerged as the most effective agents for reducing manic symptoms.
(2) Tolerability:
- Atypical antipsychotics like Olanzapine, Risperidone, and Quetiapine offered a better balance between efficacy and tolerability.
- Haloperidol showed high efficacy but lower tolerability due to adverse effects such as extrapyramidal symptoms.
(3) Lithium:
- Lithium was moderately effective but lagged behind antipsychotics like olanzapine and risperidone in terms of acute efficacy.
Key Findings: Kishi et al. (2022)
This study incorporated data from 77 RCTs, including newer medications and long-term evidence. Key findings included:
(1) Most Effective Drugs:
- Aripiprazole, Asenapine, Carbamazepine, Cariprazine, Haloperidol, Lithium, Olanzapine, Paliperidone, Quetiapine, Risperidone, Tamoxifen, Valproate & Ziprasidone showed a better response to treatment than placebo
(2) Tolerability:
- Aripiprazole, Olanzapine, Quetiapine & Risperidone had lower all-cause discontinuation.
- Topiramate had higher all-cause discontinuation
(3) Lithium:
- Lithium retained its position as an effective mood stabilizer but was less favorable in acute mania due to slower onset of action.
Psychiatry Education Forum Academy has discussed this topic in more detail (in 20 min video) by answering the following questions:
- Comparing medications for their Efficacy (Response) and Risks (Discontinuations).
- Which medications should NOT be used for acute manic episodes?
- Among Antipsychotics: which ones are preferred?
- Which medications resulted in fewer discontinuation risks?
Here is one slide from this presentation, comparing both studies findings for medications showing positive response in acute mania management:
Comparing Studies Findings:
Medications Showing Positive Response for Acute Mania
FOR ACADEMY MEMBERS:
INTERESTED IN ACCESS TO THIS & OTHER CLINICALLY RELEVANT LECTURE SERIES?
JOIN ACADEMY MEMBERSHIP:
This is a closed membership for medical professionals only.
- 400+ Clinically Relevant Chapters: Each chapter within these sections is of direct clinical relevance for your daily practice. (Table of Content)
- Journal Club: we will post the most recently published psychiatry articles relevant to your daily clinical practice. (Read Content)
- Clinical Case Discussion: Dr. Singh (Psychiatry) and Dr. Kaur (Family Medicine) discuss clinical cases to integrate the clinical cases from Psychiatry and Medicine. (Read Content)
- Monthly Insights: Gain access to our monthly sessions featuring the latest on recent publications, new medication approvals, FDA updates, and more. (Monthly Insights)
- Discussion Forum & Community: Connect with other medical professionals and discuss your difficult-to-treat clinical cases. (Academy Network)
- Goal: is to have all important clinically relevant topics in one place for ease of access.
DISCOUNTS AVAILABLE FOR: Residents & Students ONLY.
Email us your student information (program information and way to confirm your student status) to: [email protected]
© 2025 All Rights Reserved.
